Page last updated: 2024-08-23

dermatan sulfate and Phlegmasia Alba Dolens

dermatan sulfate has been researched along with Phlegmasia Alba Dolens in 51 studies

Research

Studies (51)

TimeframeStudies, this research(%)All Research%
pre-199011 (21.57)18.7374
1990's39 (76.47)18.2507
2000's1 (1.96)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gacko, M; Kowalewski, R; Malkowski, A; Rutkowska, I; Sobolewski, K1
Hobbelen, PM; Meuleman, DG; Moelker, HC; van Dedem, G1
Abildgaard, U; Larsen, ML1
Bucknall, T; Cade, J; Gallus, A; Hepburn, S; Maas, M; Magnani, H; Ockelford, P; Porteous, F; Stevens, J1
Cziraky, MJ; Egberts, JF; Leibowitz, DA; Magnani, HN; Meuleman, DG; Nicholson, CD; Spinler, SA1
Cyran, J; Greinacher, A; Scheffold, N1
Cohen, AT; Cooper, DJ; Das, SK; Edmondson, RA; Kakkar, VV; Melissari, E; Phillips, MJ; Skinner, JA; Thomas, EM1
Kleinschmidt, S; Seyfert, UT1
Agnelli, G; Damiani, M; Dupouy, D; Gianese, F; Houin, G; Imbimbo, BP; Saivin, S; Sié, P1
Cesmeli, S; Davies, AB; Gray, E; Lane, DA; Lormeau, JC1
Agnelli, G; Boschetti, E; Cosmi, B; Lupattelli, L; Nenci, GG; Radicchia, S; Rinonapoli, E; Veschi, F1
Barbanti, M; Calanni, F; Colucci, M; Marchi, E; Milani, MR; Semeraro, N1
Greinacher, A; Kirschke, W; Klement, D; Kniemeyer, HW; Rammos, S; v Kries, R1
Boneu, B2
Andreozzi, GM; Di Pino, L; Marchitelli, E; Martini, R; Palazzini, E; Pinto, A; Romeo, S; Signorelli, S; Zamboni, V1
Agnelli, G; Ascani, A; Nenci, GG; Parise, P; Radicchia, S1
Cazenave, JP; Chakfe, N; Grunebaum, L; Kretz, JG; Palazzini, E; Wiesel, ML; Zamboni, V1
Claeys, L; Ehringer, H; Huk, I; Koppensteiner, R; Kyrle, PA; Minar, E; Muhm, M; Polterauer, P; Stümpflen, A1
Bergqvist, D3
Turpie, AG2
Abedinpour, F; Berberich, R; Dumas, R; Egberts, JF; Gregoire, F; Jerkovic, M; Kutnowski, M; Nikolic, I; Woitinas, F; Zoeckler, S1
Wade, WE1
Ermacora, P; Lemesle, FG; Lhuillier, P; Marfaing, A; Mebroukine, L; Wolf, M1
Bergqvist, D; Lindblad, B; Mätzsch, T1
ten Cate, JW1
Bachmann, F; Bohnet, J; Breyer, HG; Estoppey, D; Haas, S; Hochreiter, J; Jakubek, H; Leyvraz, P; Mair, J; Sorensen, R1
Alvarez, R; Fussi, F; Santoro, FM1
Côte, R; Geerts, W; Gent, M; Ginsberg, JS; Jay, R; Leclerc, J; Levine, MN; Neemeh, J; Powers, PJ; Turpie, AG1
Boneu, B; Caranobe, C; Crepon, B; Houin, G; Level, M; Lormeau, JC; Petitou, M; Saivin, S; Sie, P1
Cuppini, S; Gianese, F; Maffei Faccioli, A; Meduri, F; Polistena, P; Prandoni, P; Toniato, A; Zangrandi, F1
Büller, HR; Hamelynck, KJ; Hoek, JA; Knipscheer, HC; Magnani, HN; Marti, RK; Nurmohamed, MT; ten Cate, H; ten Cate, JW1
Agnelli, G; Barzi, F; Cosmi, B; Di Filippo, P; Gianese, F; Longetti, M; Lupattelli, L; Ranucci, V; Renga, C; Veschi, F1
Gerhart, TN; Lee, MA; Robertson, LK; Salzman, EW; Smith, M; Yett, HS1
Bergqvist, D; Cederholm, C; Faunø, P; Fredin, H; Jensen, LJ; Justesen, T; Karjalainen, P; Kettunen, K; Soimakallio, S; Suomalainen, O1
Fareed, J; Hoppensteadt, D; Nurmohamed, MT; ten Cate, JW; Walenga, JM1
Agnelli, G; Cosmi, B; Di Filippo, P; Lupattelli, L; Mosca, S; Nenci, GG; Ranucci, V; Renga, C; Rinonapoli, E1
Buchanan, MR; Gray, E; Ofosu, FA; Van Ryn-McKenna, J; Weber, E1
Gallus, A; Magnani, H; Marshall, V; Morris, M; Murphy, W; Nacey, J; Sutherland, P1
Buchanan, MR; Gray, E; Hirsh, J; Ofosu, FA; Van Ryn-McKenna, J1
Barrowcliffe, TW; Merton, RE; Thomas, DP1
Duckert, F; Marbet, GA; Zbinden, B1
Abbadini, M; Borowska, A; Donati, MB; Maggi, A; Pagella, PG; Pangrazzi, J1
Merton, RE; Thomas, DP1
Cade, JF; Chong, BH; Grigg, LE; Kiers, L; Street, PR1
Cade, JF; Magnani, HN; Westlake, GW; Wood, M1

Reviews

8 review(s) available for dermatan sulfate and Phlegmasia Alba Dolens

ArticleYear
Glycosaminoglycans: clinical use.
    Seminars in thrombosis and hemostasis, 1996, Volume: 22, Issue:2

    Topics: Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Heparin, Low-Molecular-Weight; Humans; Postoperative Complications; Thrombophlebitis

1996
New antithrombotic agents for the prevention and treatment of deep vein thrombosis.
    Haemostasis, 1996, Volume: 26 Suppl 4

    Topics: Anticoagulants; Antithrombin III; Binding Sites; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Multicenter Studies as Topic; Oligosaccharides; Postoperative Complications; Pulmonary Embolism; Recurrence; Thrombin; Thrombophlebitis

1996
New approaches to prevention of deep vein thrombosis.
    Thrombosis and haemostasis, 1997, Volume: 78, Issue:1

    Topics: Anticoagulants; Antithrombins; Dermatan Sulfate; Humans; Platelet Aggregation Inhibitors; Postoperative Care; Preoperative Care; Thromboembolism; Thrombophlebitis

1997
Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: an assessment of currently available literature.
    Thrombosis research, 1998, Feb-15, Volume: 89, Issue:4

    Topics: Brain Ischemia; Chondroitin Sulfates; Clinical Trials as Topic; Cost-Benefit Analysis; Dalteparin; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; MEDLINE; Thrombophlebitis

1998
Modern aspects of prophylaxis and therapy for venous thrombo-embolic disease.
    The Australian and New Zealand journal of surgery, 1998, Volume: 68, Issue:7

    Topics: Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Drug Administration Schedule; Drug Combinations; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Pulmonary Embolism; Thromboembolism; Thrombophlebitis

1998
Glycosaminoglycans in prophylaxis against venous thromboembolism.
    Advances in experimental medicine and biology, 1992, Volume: 313

    Topics: Dermatan Sulfate; Dihydroergotamine; Glycosaminoglycans; Heparin, Low-Molecular-Weight; Humans; Pentosan Sulfuric Polyester; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis

1992
Orgaran in the prevention of deep vein thrombosis in stroke patients.
    Haemostasis, 1992, Volume: 22, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Glycosaminoglycans; Hemiplegia; Heparin; Heparinoids; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Pulmonary Embolism; Thrombophlebitis

1992
Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.
    Seminars in thrombosis and hemostasis, 1991, Volume: 17 Suppl 2

    Topics: Animals; Anticoagulants; Blood Coagulation; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation, Preclinical; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Incidence; Mammals; Molecular Weight; Platelet Aggregation; Postoperative Complications; Rabbits; Renal Dialysis; Thrombocytopenia; Thrombophlebitis; Thrombosis

1991

Trials

22 trial(s) available for dermatan sulfate and Phlegmasia Alba Dolens

ArticleYear
Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison. ANZ-Organon Investigators' Group.
    Thrombosis and haemostasis, 1993, Oct-18, Volume: 70, Issue:4

    Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Elective Surgical Procedures; Female; Gastrointestinal Neoplasms; Glycosaminoglycans; Hematologic Tests; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Lung Neoplasms; Male; Middle Aged; Postoperative Complications; Pulmonary Embolism; Thrombophlebitis

1993
A dose ranging study to evaluate dermatan sulphate in preventing deep vein thrombosis following total hip arthroplasty.
    Thrombosis and haemostasis, 1994, Volume: 72, Issue:6

    Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Dermatan Sulfate; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Follow-Up Studies; Hip Prosthesis; Humans; Male; Middle Aged; Phlebography; Postoperative Complications; Pulmonary Embolism; Reference Values; Risk Factors; Thrombophlebitis

1994
Heparin-associated thrombocytopenia (HAT)--still a diagnostic and therapeutical problem in clinical practice.
    Angiology, 1995, Volume: 46, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arterial Occlusive Diseases; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Female; Gangrene; Heparin; Heparitin Sulfate; Humans; Middle Aged; Phenprocoumon; Platelet Activation; Platelet Aggregation; Platelet Count; Pulmonary Embolism; Recurrence; Systemic Inflammatory Response Syndrome; Thrombocytopenia; Thromboembolism; Thrombophlebitis

1995
Intramuscular dermatan sulfate MF701 in patients with hip fracture: relationship between pharmacokinetics and antithrombotic efficacy.
    Thrombosis and haemostasis, 1994, Volume: 71, Issue:5

    Topics: Aged; Aged, 80 and over; Anticoagulants; Dermatan Sulfate; Double-Blind Method; Female; Hip Fractures; Humans; Injections, Intramuscular; Male; Middle Aged; Thrombin Time; Thrombophlebitis; Treatment Outcome

1994
Features of thrombi and diagnostic accuracy of impedance plethysmography in symptomatic and asymptomatic deep vein thrombosis.
    Thrombosis and haemostasis, 1993, Aug-02, Volume: 70, Issue:2

    Topics: Dermatan Sulfate; Double-Blind Method; Evaluation Studies as Topic; False Negative Reactions; Female; Hip Fractures; Hip Prosthesis; Humans; Male; Middle Aged; Phlebography; Plethysmography, Impedance; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Thrombophlebitis

1993
Tolerability and clinical efficacy of desmin in the treatment of superficial thrombovaricophlebitis.
    Angiology, 1996, Volume: 47, Issue:9

    Topics: Adult; Aged; Dermatan Sulfate; Female; Fibrinolytic Agents; Humans; Injections, Intramuscular; Injections, Subcutaneous; Male; Middle Aged; Molecular Weight; Thrombophlebitis; Varicose Veins

1996
Distribution and occlusiveness of thrombi in patients with surveillance detected deep vein thrombosis after hip surgery.
    Thrombosis and haemostasis, 1996, Volume: 75, Issue:2

    Topics: Aged; Anticoagulants; Dermatan Sulfate; Female; Femoral Vein; Heparinoids; Hip Fractures; Hip Prosthesis; Humans; Incidence; Male; Middle Aged; Phlebography; Plethysmography, Impedance; Popliteal Vein; Postoperative Care; Postoperative Complications; Thrombophlebitis; Ultrasonography

1996
The treatment of deep vein thrombosis with continuous intravenous low-molecular-weight dermatan sulphate (Desmin). A pilot study.
    Thrombosis research, 1996, Dec-15, Volume: 84, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Dermatan Sulfate; Desmin; Factor Xa; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Thrombophlebitis

1996
A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke.
    Age and ageing, 1994, Volume: 23, Issue:6

    Topics: Aged; Aged, 80 and over; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Injections, Subcutaneous; Male; Thrombophlebitis; Treatment Outcome

1994
Orgaran in hip fracture surgery.
    Haemostasis, 1992, Volume: 22, Issue:2

    Topics: Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Female; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Hip Fractures; Humans; Incidence; Male; Postoperative Complications; Pulmonary Embolism; Scandinavian and Nordic Countries; Single-Blind Method; Thrombophlebitis; United States; Warfarin

1992
Prevention of deep vein thrombosis following total hip replacement surgery by Orgaran. Summary.
    Haemostasis, 1992, Volume: 22, Issue:2

    Topics: Chondroitin Sulfates; Dermatan Sulfate; Dihydroergotamine; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Hip Prosthesis; Humans; Incidence; Pulmonary Embolism; Single-Blind Method; Thrombophlebitis; Treatment Outcome

1992
Orgaran in the prevention of deep vein thrombosis in stroke patients.
    Haemostasis, 1992, Volume: 22, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Glycosaminoglycans; Hemiplegia; Heparin; Heparinoids; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Pulmonary Embolism; Thrombophlebitis

1992
Thromboembolic prophylaxis in total hip replacement: a comparison between the low molecular weight heparinoid Lomoparan and heparin-dihydroergotamine.
    The British journal of surgery, 1992, Volume: 79, Issue:9

    Topics: Aged; Blood Loss, Surgical; Chondroitin Sulfates; Dermatan Sulfate; Dihydroergotamine; Drug Combinations; Female; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hip Prosthesis; Humans; Male; Prospective Studies; Thromboembolism; Thrombophlebitis

1992
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
    Annals of internal medicine, 1992, Sep-01, Volume: 117, Issue:5

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antithrombin III; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Fibrinolytic Agents; Follow-Up Studies; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombophlebitis

1992
Dermatan sulphate: a safe approach to prevention of postoperative deep vein thrombosis.
    The British journal of surgery, 1992, Volume: 79, Issue:6

    Topics: Adult; Aged; Dermatan Sulfate; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Plethysmography, Impedance; Postoperative Complications; Prospective Studies; Thrombophlebitis

1992
Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid.
    Thrombosis and haemostasis, 1992, Jan-23, Volume: 67, Issue:1

    Topics: Aged; Blood Loss, Surgical; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Glycosaminoglycans; Heparitin Sulfate; Hip Prosthesis; Humans; Male; Middle Aged; Safety; Thrombophlebitis

1992
A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture.
    Thrombosis and haemostasis, 1992, Feb-03, Volume: 67, Issue:2

    Topics: Aged; Dermatan Sulfate; Double-Blind Method; Drug Monitoring; Female; Hip Fractures; Humans; Male; Middle Aged; Risk Factors; Thrombophlebitis

1992
Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial.
    The Journal of bone and joint surgery. American volume, 1991, Volume: 73, Issue:4

    Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparinoids; Heparitin Sulfate; Hip Fractures; Humans; Iodine Radioisotopes; Male; Middle Aged; Molecular Weight; Plethysmography; Postoperative Complications; Prevalence; Prospective Studies; Risk Factors; Thrombophlebitis; Warfarin

1991
Thromboprophylaxis in patients with hip fractures: a prospective, randomized, comparative study between Org 10172 and dextran 70.
    Surgery, 1991, Volume: 109, Issue:5

    Topics: Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Female; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparitin Sulfate; Hip Fractures; Humans; Male; Single-Blind Method; Thrombophlebitis

1991
Impedance plethysmography in the diagnosis of asymptomatic deep vein thrombosis in hip surgery. A venography-controlled study.
    Archives of internal medicine, 1991, Volume: 151, Issue:11

    Topics: Aged; Dermatan Sulfate; Evaluation Studies as Topic; Female; Heparin; Hip Joint; Humans; Male; Phlebography; Plethysmography, Impedance; Postoperative Complications; Predictive Value of Tests; Sensitivity and Specificity; Thrombophlebitis

1991
The influence of Org 10172, an antithrombotic heparinoid, on urinary blood loss after transurethral prostatectomy.
    Thrombosis research, 1989, Oct-15, Volume: 56, Issue:2

    Topics: Aged; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Glycosaminoglycans; Hematuria; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Prostatectomy; Randomized Controlled Trials as Topic; Thrombophlebitis; Urologic Diseases

1989
Early clinical experience of a new heparinoid, Org 10172, in prevention of deep venous thrombosis.
    Thrombosis research, 1987, Mar-01, Volume: 45, Issue:5

    Topics: Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Factor X; Factor Xa; Female; Glycosaminoglycans; Hemorrhage; Heparitin Sulfate; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Pilot Projects; Research Design; Thoracic Surgery; Thrombophlebitis

1987

Other Studies

22 other study(ies) available for dermatan sulfate and Phlegmasia Alba Dolens

ArticleYear
Glycosaminoglycan-degrading enzymes in the varicose vein wall.
    International angiology : a journal of the International Union of Angiology, 2008, Volume: 27, Issue:6

    Topics: Adult; beta-N-Acetylhexosaminidases; Chondroitin Sulfates; Colorimetry; Dermatan Sulfate; Female; Glycosaminoglycans; Glycoside Hydrolases; Heparitin Sulfate; Humans; Hyaluronic Acid; Iduronidase; Male; N-Acetylgalactosamine-4-Sulfatase; Saphenous Vein; Sulfatases; Thrombophlebitis; Varicose Veins

2008
A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: a survey of its pharmacological properties in experimental animal models.
    Thrombosis research, 1982, Aug-01, Volume: 27, Issue:3

    Topics: Animals; Blood Coagulation; Blood Platelets; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Male; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains; Thrombophlebitis

1982
Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
    Thrombosis research, 1984, Aug-01, Volume: 35, Issue:3

    Topics: Antithrombin III Deficiency; Antithrombins; Chromogenic Compounds; Dermatan Sulfate; Disseminated Intravascular Coagulation; Glycoproteins; Heparin Cofactor II; Humans; Liver Cirrhosis; Oligopeptides; Thrombin; Thrombophlebitis

1984
Danaparoid is not a low-molecular-weight heparin.
    American journal of hospital pharmacy, 1994, Aug-15, Volume: 51, Issue:16

    Topics: Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Terminology as Topic; Thrombophlebitis

1994
[Intracardial thrombus formation in heparin-associated thrombocytopenia type II].
    Deutsche medizinische Wochenschrift (1946), 1995, Apr-13, Volume: 120, Issue:15

    Topics: Aged; Antibodies; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Chondroitin Sulfates; Coronary Thrombosis; Dermatan Sulfate; Echocardiography; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Mitral Valve Stenosis; Partial Thromboplastin Time; Phenprocoumon; Platelet Count; Thrombocytopenia; Thrombophlebitis

1995
Low affinity heparin is an antithrombotic agent.
    Thrombosis and haemostasis, 1994, Volume: 71, Issue:2

    Topics: Animals; Bleeding Time; Dermatan Sulfate; Disease Models, Animal; Hemorrhage; Heparin; Humans; Metabolic Clearance Rate; Rabbits; Thrombin; Thrombophlebitis

1994
Therapeutic effect of a low molecular weight dermatan sulphate (Desmin 370) in rat venous thrombosis--evidence for an anticoagulant-independent mechanism.
    Thrombosis and haemostasis, 1993, Feb-01, Volume: 69, Issue:2

    Topics: Animals; Blood Coagulation; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hemostasis; Male; Molecular Weight; Rats; Rats, Sprague-Dawley; Thrombophlebitis

1993
Heparin as a cause of thrombus progression. Heparin-associated thrombocytopenia is an important differential diagnosis in paediatric patients even with normal platelet counts.
    European journal of pediatrics, 1996, Volume: 155, Issue:1

    Topics: Adolescent; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Male; Platelet Activation; Thrombocytopenia; Thrombophlebitis

1996
Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
    Wiener klinische Wochenschrift, 1997, Feb-28, Volume: 109, Issue:4

    Topics: Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Dose-Response Relationship, Drug; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation; Pulmonary Embolism; Thrombocytopenia; Thrombophlebitis

1997
Prophylaxis of venous thromboembolism in stroke patients.
    Seminars in thrombosis and hemostasis, 1997, Volume: 23, Issue:2

    Topics: Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Randomized Controlled Trials as Topic; Thrombophlebitis

1997
Ardeparin and danaparoid for prevention of deep vein thrombosis.
    The Medical letter on drugs and therapeutics, 1997, Oct-10, Volume: 39, Issue:1011

    Topics: Abdomen; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Randomized Controlled Trials as Topic; Thrombocytopenia; Thrombophlebitis

1997
[Thrombosis, low-molecular-weight heparin-induced thrombocytopenia and labor].
    Presse medicale (Paris, France : 1983), 1998, Jan-10, Volume: 27, Issue:1

    Topics: Adult; Antithrombin III; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparitin Sulfate; Humans; Obstetric Labor Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Thrombocytopenia; Thrombophlebitis; Ultrasonography, Doppler

1998
[Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1998, Volume: 69, Issue:11 Suppl M

    Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Recombinant Proteins; Thrombocytopenia; Thrombophlebitis

1998
Pharmacological profile of a native dermatan sulfate.
    Thrombosis research, 1992, Jul-15, Volume: 67, Issue:2

    Topics: Animals; Bleeding Time; Blood Coagulation; Dermatan Sulfate; Disease Models, Animal; Fibrinolysis; Male; Rats; Rats, Wistar; Thrombophlebitis

1992
Antithrombotic activity, bleeding effect and pharmacodynamics of a succinyl derivative of dermatan sulphate in rabbits.
    British journal of haematology, 1992, Volume: 80, Issue:4

    Topics: Animals; Bleeding Time; Blood Coagulation; Dermatan Sulfate; Dose-Response Relationship, Drug; Rabbits; Rats; Succinates; Thrombophlebitis

1992
Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
    Thrombosis and haemostasis, 1989, Feb-28, Volume: 61, Issue:1

    Topics: Animals; Chondroitin; Dermatan Sulfate; Factor Xa; Female; Fibrinolytic Agents; Heparin; Male; Pentosan Sulfuric Polyester; Polysaccharides; Rabbits; Serine Proteinase Inhibitors; Thrombin; Thrombophlebitis; Thromboplastin

1989
Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo.
    Annals of the New York Academy of Sciences, 1989, Volume: 556

    Topics: Animals; Chondroitin; Dermatan Sulfate; Factor Xa; Female; Fibrin; Heparin; Kinetics; Male; Prothrombin; Rabbits; Serine Proteinase Inhibitors; Thrombin; Thrombophlebitis

1989
Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.
    Annals of the New York Academy of Sciences, 1989, Volume: 556

    Topics: Animals; Dermatan Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa; Glycosaminoglycans; Heparin; Oligosaccharides; Partial Thromboplastin Time; Rabbits; Serine Proteinase Inhibitors; Thrombin; Thrombophlebitis

1989
[Constitutional dysfunction of heparin cofactor II with a tendency for venous thrombosis].
    Schweizerische medizinische Wochenschrift, 1988, Oct-29, Volume: 118, Issue:43

    Topics: Adolescent; Adult; Antithrombins; Dermatan Sulfate; Female; Glycoproteins; Heparin Cofactor II; Humans; Male; Middle Aged; Pulmonary Embolism; Thrombophlebitis

1988
Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model.
    Haemostasis, 1987, Volume: 17, Issue:6

    Topics: Animals; Bleeding Time; Chondroitin; Dermatan Sulfate; Heparitin Sulfate; Male; Rats; Rats, Inbred Strains; Thrombophlebitis; Vena Cava, Inferior

1987
Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
    Thrombosis and haemostasis, 1987, Oct-28, Volume: 58, Issue:3

    Topics: Animals; Anticoagulants; Chondroitin; Dermatan Sulfate; Fibrinolytic Agents; Heparin; Humans; In Vitro Techniques; Rabbits; Thrombin; Thrombophlebitis

1987
Use of Org 10,172 in the treatment of heparin-induced thrombocytopenia and thrombosis.
    Australian and New Zealand journal of medicine, 1986, Volume: 16, Issue:5

    Topics: Aged; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; Thrombocytopenia; Thrombophlebitis

1986